An update on the use of immunotherapy in patients with colorectal cancer
- 9 November 2020
- journal article
- other
- Published by Taylor & Francis in Expert Review of Gastroenterology & Hepatology
- Vol. 15 (3) , 291-304
Abstract
Introduction: Colorectal cancer (CRC) is the third most common malignancy worldwide, with recent trends demonstrating increasing incidence amongst younger patients. Despite multiple treatment options, metastatic disease remains incurable. A new therapeutic strategy to harness the host immune system, specifically with immune checkpoint inhibitors, now has reported results from a number of clinical trials. Areas covered: This review will discuss in detail microsatellite instability (MSI) and other biomarkers for response to immunotherapy, summarize the pivotal clinical trials of immune checkpoint inhibitors in early-stage and metastatic MSI colorectal cancer, explore strategies to induce treatment responses in MSS CRC and highlight the emerging treatments and novel immune-based therapies under investigation. Expert opinion: Immunotherapy is now a standard of care for the proportion of CRC patients with MSI. While overall survival data are still awaited, the promise of profound and durable responses is highly anticipated. The lack of efficacy in MSS CRC is disappointing and strategies to convert these ‘cold’ tumors are needed. Further elucidation of optimal use of treatment sequences, combinations and novel agents will improve outcomes.Keywords
This publication has 94 references indexed in Scilit:
- Microsatellite Instability and BRAF Mutation Testing in Colorectal Cancer PrognosticationJNCI: Journal of the National Cancer Institute, 2013
- Prognostic impact of β-2-microglobulin expression in colorectal cancers stratified by mismatch repair statusJournal of Clinical Pathology, 2012
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerNew England Journal of Medicine, 2012
- Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trialBritish Journal of Cancer, 2012
- Tumour‐infiltrating T‐cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature reviewThe Journal of Pathology, 2010
- Clinical Relevance of Microsatellite Instability in Colorectal CancerJournal of Clinical Oncology, 2010
- EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndromeGenetics in Medicine, 2009
- Screening for the Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)New England Journal of Medicine, 2005
- Clinicopathologic features in colorectal cancer patients with microsatellite instabilityMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2004
- Microsatellites: simple sequences with complex evolutionNature Reviews Genetics, 2004